PFC
IPXL

Phocas Financial Corp’s Impax Laboratories, Inc. IPXL Stock Holding History

Phocas Financial Corp’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-144,159
Closed -$4.62M – 261
2016
Q1 		$4.62M Sell
144,159
-6,053
-4% -$213K 0.35% 131
2015
Q4 		$6.42M Buy
150,212
+10,646
+8% +$425K 0.5% 86
2015
Q3 		$4.91M Buy
139,566
+9,442
+7% +$425K 0.42% 113
2015
Q2 		$5.97M Sell
130,124
-4,460
-3% -$212K 0.48% 95
2015
Q1 		$6.31M Buy
134,584
+22,372
+20% +$890K 0.5% 91
2014
Q4 		$3.56M Buy
+112,212
New +$3.28M 0.31% 140

Other funds holding IPXL

HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Phocas Financial Corp's IPXL Position: Q2 2016 in Review

Phocas Financial Corp sold out of Impax Laboratories, Inc. (IPXL) in Q2 2016, closing a stake of 144,159 shares — an estimated $4.62M sold.

Phocas Financial Corp first reported a position in IPXL in Q4 2014 and held it in 6 quarters. The position peaked at $6.42M in Q4 2015. 198 funds tracked by Wall St. Rank hold IPXL as of Q2 2016.

  • Phocas Financial Corp reported no remaining Impax Laboratories, Inc. position as of Q2 2016 after selling out during the quarter.
  • Phocas Financial Corp sold 144,159 Impax Laboratories, Inc. shares in Q2 2016, an estimated $4.62M.
  • Phocas Financial Corp first reported a position in Impax Laboratories, Inc. in Q4 2014 and held it in 6 quarters.
  • Phocas Financial Corp's Impax Laboratories, Inc. position peaked at $6.42M in Q4 2015.
  • 198 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2016.

Based on Phocas Financial Corp's 13F filing for Q2 2016, filed 15 Aug 2016.